RT Journal
A1 Moser M
T1 National recommendations for the pharmacological treatment of hypertension: Should they be revised?
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 1999
FD July 12
VO 159
IS 13
SP 1403
OP 1406
DO 10.1001/archinte.159.13.1403
UL http://dx.doi.org/10.1001/archinte.159.13.1403
AB 
SINCE PUBLICATION of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) in the November 24, 1997, issue of the ARCHIVES,1 several long-term morbidity and mortality trials and several comparative medication studies have been published. It is of interest to review the rationale for the JNC VI recommendations and discuss possible revisions that may be indicated on the basis of data from these new trials.